- Home
- TEAF vs LFCR Comparison
TEAF vs LFCR Comparison
Compare TEAF & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEAF
- LFCR
- Stock Information
- Founded
- TEAF 2017
- LFCR 1986
- Country
- TEAF United States
- LFCR United States
- Employees
- TEAF N/A
- LFCR N/A
- Industry
- TEAF Trusts Except Educational Religious and Charitable
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- TEAF Finance
- LFCR Health Care
- Exchange
- TEAF Nasdaq
- LFCR Nasdaq
- Market Cap
- TEAF 174.8M
- LFCR 164.3M
- IPO Year
- TEAF N/A
- LFCR N/A
- Fundamental
- Price
- TEAF $12.51
- LFCR $6.40
- Analyst Decision
- TEAF
- LFCR Buy
- Analyst Count
- TEAF 0
- LFCR 2
- Target Price
- TEAF N/A
- LFCR $8.00
- AVG Volume (30 Days)
- TEAF 56.1K
- LFCR 174.3K
- Earning Date
- TEAF 01-01-0001
- LFCR 10-04-2024
- Dividend Yield
- TEAF 9.20%
- LFCR N/A
- EPS Growth
- TEAF N/A
- LFCR N/A
- EPS
- TEAF N/A
- LFCR 0.17
- Revenue
- TEAF N/A
- LFCR $128,443,999.00
- Revenue This Year
- TEAF N/A
- LFCR $2.23
- Revenue Next Year
- TEAF N/A
- LFCR $8.40
- P/E Ratio
- TEAF N/A
- LFCR $44.60
- Revenue Growth
- TEAF N/A
- LFCR 23.42
- 52 Week Low
- TEAF $11.11
- LFCR $3.68
- 52 Week High
- TEAF $13.30
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- TEAF 33.68
- LFCR 58.32
- Support Level
- TEAF $12.57
- LFCR $5.56
- Resistance Level
- TEAF $12.64
- LFCR $7.23
- Average True Range (ATR)
- TEAF 0.14
- LFCR 0.35
- MACD
- TEAF -0.04
- LFCR 0.04
- Stochastic Oscillator
- TEAF 7.67
- LFCR 51.18
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a US-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.